Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
Formats
RDF:
N-Triples
N3
Turtle
JSON
XML
OData:
Atom
JSON
Microdata:
JSON
HTML
Embedded:
JSON
Turtle
Other:
CSV
JSON-LD
Faceted Browser
Sparql Endpoint
About:
AbCellera
An Entity of Type:
Public company
,
from Named Graph:
http://dbpedia.org
,
within Data Space:
dbpedia-live.demo.openlinksw.com
Company in Vancouver, Canada
Property
Value
dbo:
description
bedrijf uit Canada
(nl)
company in Vancouver, Canada
(en)
Biotech-Firma aus British Columbia
(de)
biotekniskt företag i Kanada
(sv)
カナダのヴァンクーヴァーに本社を置くバイオテクノロジー企業
(ja)
dbo:
foundingYear
2012-01-01
(xsd:gYear)
dbo:
industry
dbr
:Contract_research_organization
dbo:
location
dbr
:British_Columbia
dbr
:Vancouver
dbo:
netIncome
-1.63E8
(dbd:usDollar)
dbo:
numberOfEmployees
386
(xsd:nonNegativeInteger)
dbo:
type
dbr
:Public_company
dbo:
wikiPageWikiLink
dbr
:Peter_Thiel
dbr
:British_Columbia
dbr
:Vancouver
dbr
:Merck_&_Co.
dbr
:Respiratory_syncytial_virus
dbr
:Tuberculosis
dbr
:Eli_Lilly_and_Company
dbr
:University_of_British_Columbia
dbr
:Bill_&_Melinda_Gates_Foundation
dbr
:COVID-19
dbc
:Companies_listed_on_the_Nasdaq
dbr
:Biotechnology
dbc
:Companies_based_in_Vancouver
dbr
:Novartis
dbc
:Canadian_companies_established_in_2012
dbr
:Ablynx
dbr
:Antibody
dbr
:Monoclonal_antibody_therapy
dbr
:Messenger_RNA
dbr
:DARPA
dbr
:Food_and_Drug_Administration
dbr
:Pfizer
dbr
:Sanofi
dbr
:Gilead_Sciences
dbr
:Variants_of_SARS-CoV-2
dbc
:Biotechnology_companies_of_Canada
dbr
:Emergency_Use_Authorization
dbr
:Teva_Pharmaceutical_Industries
dbr
:Monoclonal_antibodies
dbr
:Biological_Technologies_Office_(DARPA)
dbr
:Moderna
dbr
:Series_A_round
dbr
:Public_Company
dbr
:Vancouver,_British_Columbia
dbr
:GlaxoSmithKline
dbr
:LY-CoV555
dbr
:Pandemic_Prevention_Platform
dbr
:Series_B_round
dbp:
industry
dbr
:Contract_research_organization
dbp:
location
dbr
:British_Columbia
dbr
:Vancouver
dbp:
name
AbCellera Biologics Inc.
(en)
dbp:
netIncome
US $-163 million
(en)
dbp:
numEmployees
386
(xsd:integer)
dbp:
revenue
38000000
(xsd:integer)
dbp:
tradedAs
NASDAQ:ABCL
(en)
dbp:
type
dbr
:Public_company
dbp:
wikiPageUsesTemplate
dbt
:Start_date_and_age
dbt
:Reflist
dbt
:Infobox_company
dbt
:Decrease
dbt
:Use_Canadian_English
dbt
:Url
dbt
:Vancouver_Corporations
dbt
:Short_description
dct:
subject
dbc
:Companies_listed_on_the_Nasdaq
dbc
:Companies_based_in_Vancouver
dbc
:Canadian_companies_established_in_2012
dbc
:Biotechnology_companies_of_Canada
rdf:
type
owl
:Thing
dul
:Agent
dul
:SocialPerson
wikidata
:Q24229398
wikidata
:Q43229
wikidata
:Q4830453
dbo
:Agent
dbo
:Organisation
schema
:Organization
rdfs:
label
AbCellera
(en)
owl:
sameAs
wikidata
:AbCellera
dbpedia-global
:AbCellera
dbr
:AbCellera
prov:
wasDerivedFrom
wikipedia-en
:AbCellera?oldid=1292950027&ns=0
foaf:
isPrimaryTopicOf
wikipedia-en
:AbCellera
foaf:
name
AbCellera Biologics Inc.
(en)
is
dbo:
wikiPageRedirects
of
dbr
:AbCellera_Biologics
dbr
:Abcellera
is
dbo:
wikiPageWikiLink
of
dbr
:Bamlanivimab
dbr
:Eli_Lilly_and_Company
dbr
:AbCellera_Biologics
dbr
:Abcellera
dbr
:Bebtelovimab
dbr
:John_R._Mascola
dbr
:Biological_Technologies_Office_(DARPA)
dbr
:OrbiMed
dbr
:Responses_to_the_COVID-19_pandemic_in_August_2020
is
foaf:
primaryTopic
of
wikipedia-en
:AbCellera
This content was extracted from
Wikipedia
and is licensed under the
Creative Commons Attribution-ShareAlike 4.0 International